Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients

Debie, Y., Van Audenaerde, J. R. M., Vandamme, T., Croes, L., Teuwen, L-A., Verbruggen, L., Vanhoutte, G., Marcq, E., Verheggen, L., Le Blon, D., Peeters, B., Goossens, M. E., Pannus, P., Ariën, K. K., Anguille, S., Janssens, A., Prenen, H., Smits, E. L. J., Vulsteke, C., Lion, E. & 2 others, Peeters, M. & van Dam, P. A., 2022, (E-pub ahead of print) In: Clinical Cancer Research. 29, 3, p. 635–646

Research output: Contribution to journal › A1: Web of Science-article › peer-review